The radioactive microaphere technique was u«ed to trace regional blood flow and total cardiac output diatribution in rate in heart failure Becondary to biventricular volume overload during acute intravenous infusion of nitroglycerin. Data from rats with heart failure (chronic arteriovenous shunt) were compared to data obtained from rats subjected to sham surgical procedures. In both groups, data were obtained at rest and during treadmill exercise during alternate infusions of nitroglycerin and normal saline (control). In heart failure, nitroglycerin slightly increased cardiac output at rest and during exercise, increased stroke volume, and reduced systemic vascular resistance at rest but not during exercise. In the heart failure group, exercise reduced flow to the renal, gastrointestinal, and cutaneous circulations but had little or no effect in the sham group. Nitroglycerin dramatically increased renal, gastrointestinal, and cutaneous blood flow during exercise in the heart failure group but had minimal effects on active hyperemia in the skeletal muscle bed. In the sham group, nitroglycerin decreased blood flow in the renal, gastrointestinal, and cutaneous beds and had no effect on skeletal muscle blood flow. Thus, in the renal, gastrointestinal, and cutaneous circulations during exercise, nitroglycerin increased flow in the heart failure group and decreased flow in the sham group to the extent that the respective values in the two groups were equal. Circ Res 49: [458][459][460][461][462][463][464][465][466][467][468] 1981 
the effect of these agents to increase cardiac output in patients with heart failure appears to involve a vasodilation of the renal circulatory bed. However, there is no direct evidence demonstrating the effect of the vasodilators on the regional distribution of total cardiac output at rest or during exercise in the normal or the heart failure states.
The present study was conducted to examine the effect of intravenous nitroglycerin on cardiac output distribution at rest and during exercise in an animal model of heart failure due to chronic volume overload. The results indicate that nitroglycerin increases renal, splanchnic, and cutaneous blood flows during exercise with only minor and sporadic increases in blood flow to exercising skeletal muscle beds. Thus, the action of chronic nitroglycerin therapy may be related to its acute vasodilator effect in the renal, splanchnic, and cutaneous beds and not to a vasodilator effect in the skeletal muscle bed. If renal vasodilation results in increased renal excretion of sodium, vascular sodium may fall and decreased large vessel stiffness may result. Then nutritional flow to skeletal muscle during exercise may be increased chronically. A preliminary report of these findings has been presented previously (Weitzel et al., 1979) .
Methods \
Male Sprague-Dawley rats were housed in facilities with constant temperature exposed to a 12-hour light/12-hour dark cycle, and given standard lab chow (Wayne) and water ad libitum for a minimum of 2 weeks before initiation of experimental procedures. The mean body weight of the experimental group (n = 18) prior to surgical procedures was 351 ± 15 g. It should be noted that rats of relatively large body weight were used to allow for subsequent surgical procedures (average age = 11 wks).
Heart Failure Model
The model for heart failure used in these studies was one that simulates volume overload high output failure. This state is induced in rats by the surgical opening of a large AV shunt between the abdominal aorta and inferior vena cava. The characteristics of this model with respect to both the acute and the chronic (Flaim et ah, 1979b; states have been described previously. Within 24 hours after the opening of the AV shunt, acute volume overload develops which includes a doubling of total cardiac output due to increased stroke volume and a 50% reduction in total vascular resistance . Mean arterial pressure is reduced and left ventricular enddiastolic pressure is increased with significant fluid retention in lung and hepatic tissue . Both right and left coronary artery blood flow are increased and skeletal muscle blood flow is decreased . Chronically, the volume overload state is compensated for partially by the following mechanisms: (1) a significant biventricular hypertrophy of approximately 20% and (2) an increase in sympathetic tone as indicated by elevated plasma catecholamines (Flaim et aL, 1979b) . In this state of chronic volume overload, mean arterial pressure is normal while arterial diastolic pressure is reduced and pulse pressure increased (Flaim et al., 1979b) . Left ventricular end diastolic pressure remains elevated but tissue fluid content is normalized (Flaim et al., 1979b) . That portion of the cardiac output destined for the systemic circulation is significantly reduced, and it was found that this reduction is sustained primarily in the skeletal muscle, cutaneous, splanchnic, and renal beds, whereas cerebral, coronary, and hepatic flows are maintained at normal levels (Flaim et al., 1979b) . The ability of these animals to perform treadmill exercise is compromised due to an insufficient increase Ln systemic cardiac output and an attenuation of exercise-induced skeletal muscle vasodilation . The surgical procedures used to create the arteriovenous shunt have been described in detail previously (Flaim et al., 1979b) . Briefly, animals were anesthetized with Surital (20 mg/kg, ip), a midline incision was made in the abdominal wall, the infrarenal abdominal aorta and vena cava were exposed and isolated for a distance of approximately 20 mm, and branches were temporarily occluded. Segments (10 mm) of aorta and vena cava were isolated. A circular knife was used to make a hole of equal size (diameter = 1 mm) through each medial wall and a side-by-side anastomosis was created. The patency of the shunt was confirmed visually by the presence of mixing of arterial blood in the vena cava. The abdominal incision was closed and the animal allowed to recover. The entire surgical procedure was completed within approximately 20 minutes. The circulation to the hindquarters was obstructed for no longer than 10 minutes. These procedures resulted in a net long-term (20 days) survival rate of approximately 80%. At the time of surgery, two groups of rats were identified: the experimental group in which the AV shunt had been opened (n -10, body weight at the time of experiment = 400 ± 27 g); the sham group on which the entire surgical procedure had been performed with the exception of the opening of the AV shunt (n = 8, body weight at time of experiment = 428 ± 17 g). AD animals were allowed to recover from surgery for 20 days before experimental procedures were initiated. During the recovery period, all animals were maintained under constant conditions and provided with food and water ad libitum.
Instrumentation
On the day of study, the rats were anesthetized with halothane {2% in oxygen) and polyethylene catheters (PE 50) containing heparinized saline (Lipo-Hepin, Riker: 1000 U/ml diluted to 1 U/ml in normal saline) were placed in the left ventricle via the right carotid artery, in the caudal artery (2 cm distal to the femoral bifurcation), and in the right atrium via the jugular vein. In addition, a second catheter was placed proximally in the right jugular vein for drug infusion. Catheter positions were determined by pressure waves detected by Statham P23Gb pressure transducers and displayed on an Electronics for Medicine recorder (DR-12). The left ventricular catheter, the right atrial catheter, and the right jugular vein catheter were brought through a subcutaneous tunnel to the dorsal cervical region. After closure, animals were allowed to recover for a minimum of 3 hours before experimental procedures were initiated.
Regional Blood Plow Measurement
Radioactive microspheres (3M Co.), 15 ± 5 urn in diameter were used to measure regional blood flow according to the reference sample technique (Wagner et al., 1969; Heymann et al., 1977) as adapted for use in the rat (Flaim et al., 1978; Flaim et al., 1979a) . A detailed presentation of the radioactive microsphere technique as used in this study has been described previously (Flaim et al., 1979b; . We used four different radionuclide-labeled ( m Ce, ^Sr, ^Nb, 51 Cr) microsphere species with specific activities of approximately 12 mCi/g and suspended in normal saline plus 0.01% Tween 80 (Sigma) in alternating sequence. The Tween was added to retard micro- VOL. 49, No. 2, AUGUST 1981 sphere aggregation. The final specific activity of the microsphere suspension was approximately 0.01 mCi/rril of suspending agent. The microsphere suspension was mixed thoroughly by agitation and sonication (Heat Systems Ultrasonics Sonicator, model W200 R) immediately prior to each injection. One-half milliliter of microsphere suspension, approximately 150,000 microspheres, then was injected into the left ventricle through the catheter over a 15-second period followed immediately by a 1-ml heparinized saline flush over a 15-second period. One minute prior to the injection, blood withdrawal was begun via the caudal artery catheter at a rate of 0.2 ml/min by use of a Harvard pump (model 907). The total blood withdrawal period equaled 4 minutes for each injection. At the end of the study, rats were killed by pentobarbital injection, and organs as well as tissue samples were removed. All samples were blotted, weighed, and transferred to a two-channel y scintillation counter (Packard Auto-Gamma Spectrometer model 5230) for determination of radioactivity levels. Sample size was altered to obtain as nearly as possible equal total counts in all samples, thereby reducing error due to nonuniform counting efficiency over large ranges in emission rates. Each channel was set to record emissions at the peak energy level for one isotope through a window of 50 keV for 5 minutes. A Digital Equipment Corporation PDP 11/40 computer was programmed to calculate regional blood flow as well as total cardiac output according to the method of Wagner et al. (1969) . The program employed for these calculations compensated for crosstalk between channels.
Random samples of microspheres were analyzed periodically under a microscope to measure actual microsphere diameter and to determine the effects of sonication. The position of the peak emission energy levels for each radionuclide-tagged microsphere species was checked periodically to avoid counting errors due to drift in the detecting apparatus. The total injected counts were estimated from the average number of counts in 10 tubes; each contained the same known dilution of the total volume of each microsphere injection.
Hemodynamic Studies
Cardiac output was determined at the time of the injection with the use of the radioactive microsphere technique as described by Heymann et al. (1977) . Cardiac output data are expressed as flow per kilogram of body weight. Tracings from the caudal arterial catheters were employed to obtain peripheral arterial mean and pulse pressures. Tracings from the left ventricular catheter were used to obtain heart rate as well as left ventricular enddiastolic and peak pressures and tracings from the right atrial catheter provided an estimate of central venous pressure. Stroke volume was calculated from cardiac output and heart rate and total vas-cular resistance was determined by use of cardiac output and mean arterial pressure data. With the exception of cardiac output, stroke volume, and total vascular resistance data, hemodynamic data were collected immediately before the microsphere injection.
Measurement of Total Cardiac Output Distribution
The distribution of total cardiac output was calculated from the data for regional blood flow. For regions where total flow was not measured (cutaneous, skeletal muscle, gastrointestinal tract), estimates for each animal were made based on measured flow per hundred grams of tissue and projected body weight percentages for each tissue in rat (cutaneous, 320; skeletal muscle, 454; gastrointestinal tract, 53 g/kg of body weight) (Munro, 1964) . It should be noted that, whereas some changes in body weight distribution have been found to occur in the volume overload model of heart failure in the rat, the magnitude of these changes which are on the order of 0.1% does not significantly affect the data presented in the present study (Flaim et al., 1979b) .
Experimental Protocol
Before experimental procedures were initiated, care was taken to ensure that animals had recovered properly from anesthetic and were alert and able to execute coordinated movements. Fifteen minutes prior to the initial data collection point, infusion of either nitroglycerin (Nitrostat, Parke-Davis, in normal saline) or normal saline solution was instituted. The infusion was made through the proximal right jugular vein catheter by use of a Harvard constant infusion pump (model 907). When nitroglycerin was infused, the pump was set to deliver 8 /igAg over a 15-minute period. The actual infusion rate which varied with body weight was approximately 0.04 ml/min. Selection of this dose was based on the results of a pilot study on eight normal rats testing three dose levels of nitroglycerin infusion in a sequential dose-response fashion (2, 8, and 32 ftg/kg every 15 minutes). The intermediate dose was chosen for the present study since this was found to cause significant peripheral vasodilation in areas of the peripheral circulation predominantly under sympathetic control, whereas the highest dose tested caused a reversal of this effect due apparently to a sympathetic reflex activation. The vascular resistance data obtained for two regions (kidney and ileum) during control and nitroglycerin infusion at 2, 8, and 32 /ig/kg every 15 minutes were (kidney) 0.23, 0.20, 0.17, 0.20 mm Hg-100 g-min-ml" 1 and (ileum) 0.60, 0.38, 0.26, 0.28 mm Hg-100 g-minml ' (unpublished observations). To obtain control data in the present study and previously, we infused saline at a rate similar to that of nitroglycerin. During the last minute of each infusion period, data were collected. Subsequently, the animals were subjected to treadmill exercise during which the infusion of either normal saline or nitroglycerin was continued. The exercise protocol is summarized briefly as follows: a rat was placed in the darkened area at the front of a treadmill track. The treadmill then was started at a slow rate and the animal was allowed to walk. Using a rheostat speed control, we gradually increased the speed of the treadmill over a period of 2 minutes to a maximum rate of 39 ft/ min, a speed which has been determined previously to be approximately 30% of maximum exercise rate for normal adult untrained rats (Flaim et al, 1979a) . The animal was allowed to exercise at this rate (0°i nclination) for 5 minutes. During the last minute of the exercise protocol, data collection procedures were repeated, the treadmill and the infusion were stopped, and the animal entered into a 2-hour rest/ recovery period. Subsequently, the entire protocol, as described above, was repeated using the alternative infusion (either saline or nitroglycerin). This protocol can be repeated 4 times without significantly altering systemic hemodynamics in normal rats (unpublished observations). Studies were randomized for sham vs. heart failure and control vs. drug. After the fourth data collection had been completed, rats were killed by pentobarbital injection and tissue samples were obtained for y scintillation analysis.
Statistical Analysis of Data
Results are reported as mean ± SEM. All data were evaluated using analysis of variance followed by the Student-Newman-Keuls multiple range test (Alder and Roessler, 1972) , and a P value of less than 0.05 was considered to be significant.
Results

Quantitation of AV Shunt
In the sham group, microspheres trapped in the lungs can be attributed almost entirely to bronchial artery blood flow. In the heart failure group, on the other hand, microspheres can enter the lungs via not only the bronchial arterial circulation, but also via the pulmonary circulation as a result of the AV shunt. Thus, in the heart failure group, the magnitude of the AV shunt can be approximated if a value for total bronchial arterial blood flow normalized to body weight in the rat is known. In the present studies, such values were determined from the sham group, both at rest and during exercise during saline infusion, and were as follows: rest, 8.1 ± 1.2; exercise, 10.4 ± 3.2 ml/min per kg body weight. By use of these average values, it was possible to calculate total shunt flow and the percent of total cardiac output attributable to the shunt in the heart failure group at rest and with exercise during saline infusion: (total AV shunt flow: rest, 175.5 ± 52.7; exercise, 102.7 ± 22.4 ml/min) (% of total cardiac output: rest, 49.4 ± 8.3; exercise 30.9 ± 6.6%).
Effect of AV Shunt on Cardiac Mass
Total cardiac mass was greater in the heart failure group compared to the sham group as follows: heart failure, 3.72 ± 0.22; sham, 3.10 ± 0.11 g/kg body weight, P < 0.025. The increase in cardiac mass in the heart failure group was localized primarily in the atria and right ventricle which had significantly greater masses compared to sham, whereas the left ventricle had slightly but not significantly greater mass (atria: heart failure, 0.52 ± 0.04; sham, 0.33 ± 0.01; P < 0.001) (right ventricle: heart failure, 0.84 ± 0.04; sham, 0.67 ± 0.03; P < 0.005) (left ventricle: heart failure, 2.36 ± 0.18; sham, 2.11 ± 0.08 g/kg body weight; P > 0.2). Thus, the AV shunt across the abdominal aorta and vena cava over a 20-day duration resulted in a significant hypertrophy of the atria and right ventricular chambers.
Effect of Nitroglycerin on Cardiovascular Hemodynamics
Cardiovascular hemodynamic data obtained at rest and during treadmill exercise in sham and heart failure animals during infusion of both saline and nitroglycerin are presented, in part, in Figure 1 VOL. 49, No. 2, AUGUST 1981 all groups while having minor effects on heart rate and mean arterial pressure. Nitroglycerin slightly, but not significantly, increased cardiac output in the heart failure group at rest and during exercise, but had no such effect in the sham group (Fig. 1A) .
From Figure IB , it is clear that the heart failure group had significantly reduced heart rates compared to the respective sham data and that nitroglycerin had no effect in either group compared to saline infusion. Nitroglycerin significantly increased stroke volume (Fig. 1C) in the heart failure group at rest while having no significant effect in the sham group. Mean arterial pressure (Fig. ID) was significantly reduced in the heart failure group compared to the sham group. Nitroglycerin did not have a major effect on mean arterial pressure in either group, although a slight reduction in pressure was measured during exercise in the sham group with nitroglycerin. Nitroglycerin reduced systemic vascular resistance in the heart failure group at rest while having no effect on the sham group (Fig. IE) .
In addition, it is apparent that systemic vascular resistance was lower in the heart failure group compared to the sham group, both at rest and during exercise (Fig. IE) . Data for other hemodynamic parameters are presented in Table 1 . Left ventricular peak systolic pressure was lower in the heart failure group compared to sham, both at rest and during exercise and nitroglycerin resulted in only a slight but insignificant reduction in peak pressure in the heart failure group during exercise compared to saline and no change in the sham group. Left ventricular diastolic pressure was slightly but not significantly higher in the heart failure group at rest and during exercise, and there were no significant effects of nitroglycerin in either group. Central venous pressure increased slightly and consistently with exercise in the heart failure group although the changes were not significant, whereas no consistent change occurred in the sham group with exercise. Both systolic and diastolic arterial pressures were significantly reduced in heart failure compared to sham at both rest and exercise during both saline and nitroglycerin. Nitroglycerin had no significant effect but appeared to reduce diastolic arterial pressure during exercise in the sham group.
Effect of Nitroglycerin on Regional Blood Flow and Vascular Resistance
Data for skeletal muscle blood flow are presented in Figure 2 . Corresponding data for skeletal muscle vascular resistance are presented in Table 2 . Exercise resulted in major increases in blood flow and decreases in vascular resistance in seven of eight muscle groups studied. Exercise had very little effect on blood flow to the latissimus dorsi group ( Figure 2F ). In the heart failure group during saline infusion, exercise-induced hyperemia was significantly attenuated in the gastrocnemius (Fig. 2B ) and the soleus (Fig. 2G ) muscle groups. A similar but nonsignificant heart failure-related attenuation of exercise-induced hyperemia was measured in the triceps (Fig. 2E ) muscle group. No such attenuation of exercise-induced hyperemia occurred in the psoas ( Fig. 2A), quadriceps (fig. 2C ), or biceps (Fig. 2H ) groups. Nitroglycerin tended to increase blood flow both at rest and during exercise. This effect is most evident in the data from the heart failure group in which exercise-induced skeletal muscle hyperemia was significantly attenuated during saline infusion; i.e., gastrocnemius (Fig. 2B ). However, this effect of nitroglycerin was not statistically significant or even consistent in all the muscle groups studied. Data for skeletal muscle vascular resistance ( Table 2 ) also indicate that nitroglycerin had relatively few and inconsistent beneficial effects. In the sham group, nitroglycerin reduced resistance in two muscles in resting animals and in one muscle in exercising animals. In the heart failure group during saline REST EXERCISE
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infusion, two muscles had slightly lower resistance compared to sham at rest, two muscles had lower resistance, and one muscle had higher vascular resistance compared to sham during exercise. Nitro-glycerin significantly increased vascular resistance in one muscle group in heart failure during exercise and reduced resistance in the sham group in two muscles at rest and in one muscle during exercise. Data are mean ± SEM in unils of vascular resistance (mm Hg-g-min-ml ')-Gastroc -gaatrocnemius muscle; quad -quadriceps muscle; latisa. a latissimus dona muscle.
• Statistically significajit compared to respective sham control data. f Statistically Significant compared to resptrcuve saline control data. VOL. 49, No. 2, AUGUST 1981 It should be noted that four muscle groups in heart failure displayed significantly lower vascular resistance compared to sham during nitroglycerin at rest whereas there were no significant differences between sham and heart failure data during nitroglycerin and exercise. Thus, in this etudy, it appears that animals with heart failure had slightly lower skeletal muscle vascular resistances compared to sham and that nitroglycerin effectively eliminated this difference. Data for renal blood flow and vascular resistance are presented in Figure 3 . During saline infusion renal blood flow did not change in sham animals, and vascular resistance with exercise (Fig. 3A) . In the heart failure group, on the other hand, renal blood flow decreased dramatically from a normal resting level to a severely ischemic level during exercise. Vascular resistance in heart failure increased from a resting level significantly lower than sham to an exercise level that was significantly greater than sham (Fig. 3B ). Nitroglycerin infusion had no statistically significant effect on renal blood flow or vascular resistance in the sham group. In the heart failure group, nitroglycerin significantly attenuated the exercise-induced renal ischemia previously noted during saline infusion. Renal blood flow in heart failure with nitroglycerin during exercise was increased and not significantly different from sham. Renal vascular resistance in heart failure remained reduced compared to sham at rest during nitroglycerin. During exercise, however, the elevation in renal vascular resistance which was substantial in the heart failure group during saline infusion was lessened in that group during nitroglycerin infusion.
Data for intestinal blood flow and vascular resistance are presented in Figure 4 . These data are qualitatively similar to those obtained from the renal circulation. In the sham group, exercise caused no significant change in blood flow and vascular resistance in all three of the intestinal circulations studied. However, there was a tendency for exercise to reduce blood flow and increase vas- cular resistance in the sham group during saline infusion. Nitroglycerin infusion had no significant effect on blood flow or vascular resistance in the sham group compared to saline infusion. However, the data suggest that nitroglycerin had a tendency to reduce blood flow slightly and increase vascular resistance at both rest and exercise compared to the saline control. In the heart failure group, blood flow and vascular resistance levels during saline infusion were normal during rest, but exercise induced substantial reductions in blood flow and increases in vascular resistance in all three beds. The exercise levels in the heart failure group were significantly different from the sham control levels in all three beds. Unlike the sham group, nitroglycerin infusion in the heart failure group resulted in significant increases in exercising blood flow levels and decreases in exercising vascular resistance levels in all three beds compared to the saline control data. Thus, nitroglycerin attenuated a heart failure-related exercise ischemia response in the intestinal circulatory bed. Data for cutaneous blood flow and vascular resistance are presented in Figure 5 . As with the intestinal circulation, data from the cutaneous circulation are qualitatively similar to those from the renal circulation. Data from two different cutaneous beds were obtained; the dorsal cervical region (Fig.  5, A and B ) and the lateral hindlimb region ( Fig. 5  C and D) . Exercise caused no change in blood flow or vascular resistance in the sham group during saline infusion. During nitroglycerin infusion, sham group blood flow in the dorsal region significantly decreased with exercise ( Fig. 5A) and vascular re-sistance increased, but this change was not significant (Fig. 5B ). In the hindlimb region, nitroglycerin did not affect blood flow or vascular resistance in the sham group. In the heart failure group during saline infusion, blood flow was decreased and vascular resistance was increased compared to saline control in both the dorsal and hindlimb regions. These changes were significant in the dorsal cervical region only. Nitroglycerin infusion in the heart failure group tended to increase blood flow and reduce vascular resistance both at rest and during exercise compared to saline control. This effect was statistically significant for blood flow during exercise in the dorsal cervical region (Fig. 5A) . Thus, it appears that nitroglycerin results in an increase in blood flow and a decrease in vascular resistance levels in the cutaneous circulatory bed. Data for blood flow and vascular resistance obtained from other circulatory beds are presented in Tables 3 and 4, respectively. These data indicate that nitroglycerin had little effect in the sham group. The only change induced by nitroglycerin in the sham group occurred in data for hepatic arterial resistance (liver), which was significantly reduced by nitroglycerin infusion during exercise. In the heart failure group at rest during saline infusion, coronary blood flow was higher and vascular resistance was lower in all three chambers compared to sham. This difference was significant only in the right ventricle. Nitroglycerin increased blood flow to the atria and left ventricle and significantly reduced vascular resistance in these regions while VOL. 49, No, 2, AUGCST 1981 slightly decreasing blood flow and increasing vascular resistance in the right ventricle. Blood flow to the liver, cerebrum, and testes was higher and resistance was lower in heart failure at rest during both saline and nitroglycerin, whereas blood flow and resistance to the spleen and stomach were reduced and increased, respectively, in heart failure. As with the sham group, nitroglycerin had no sig- nificant effect in the heart failure group at rest. During exercise, nitroglycerin significantly increased blood flow and reduced vascular resistance to the spleen in the heart failure group. Data for the distribution of total systemic cardiac output at rest and during exercise in sham and heart failure groups during saline and nitroglycerin infusion are presented in Table 5 . In the sham group, nitroglycerin slightly increased the percent of cardiac output distributed to the renal circulation in resting animals and slightly decreased that going to the gastrointestinal circulation. During exercise, nitroglycerin increased cardiac output percent in the skeletal muscle bed and reduced that in the gastrointestinal bed. In the heart failure group, the percent of cardiac output going to the skin and gastrointestinal beds was reduced during saline infusion at rest, whereas that going to the coronary circulation was increased. During nitroglycerin infusion at rest, the gastrointestinal increment remained reduced compared to sham. During exercise, the percent of systemic cardiac output going to the brain and heart was increased and that going to the kidney and spleen was reduced during saline compared to sham. During nitroglycerin and exercise, there was no significant difference between the heart failure and sham groups. Nitroglycerin had no effect on the heart failure group at rest but significantly increased the percent of systemic cardiac output going to the renal circulation during exercise.
Discussion
The results of these studies indicate that nitroglycerin preferentially increased blood flow to the renal, splanchnic, and cutaneous circulations of rats with heart failure during exercise without significantly and consistently enhancing blood flow to the skeletal muscle bed. The data explain earlier observations that this vasodilator can simultaneously increase cardiac output without increasing systemic oxygen consumption (Rubin et al., 1977; Moskowitz et al., 1979; Franciosa and Conn, 1979) , observations which lead to the suggestion that skeletal muscle nutritional blood flow may not be enhanced during acute vasodilator therapy with nitroglycerin for heart failure (Zens et al., 1979) .
In the present study, acute nitroglycerin infusion caused a nonsignificant increase in cardiac output in rats with heart failure, both at rest and during exercise. There were also slight but nonsignificant reductions in left ventricular end diastolic pressure in the group with heart failure both at rest and during exercise with nitroglycerin. Nitroglycerin had little effect on heart rate but significantly increased stroke volume in the animals with heart failure at rest. The major hemodynamic effect of nitroglycerin in the group with heart failure at rest was the fall in systemic vascular resistance. This reduction in afterload is most likely attributable to the combined effect of the drug in the renal, splanchnic, and cutaneous circulations. During exercise, there was no significant change in vascular resistance with nitroglycerin in the group with heart failure. It should be noted that, in the group with heart failure, heart rate was significantly reduced both at rest and during exercise compared to the sham group. This type of response has not been seen previously in the volume overload heart failure model and the cause of this change cannot be explained readily.
An interesting observation that resulted from these studies is the fact that acute nitroglycerin administration tended to decrease regional blood flow in normal animals. Although these changes were generally not statistically significant, it is clear from Figures 3, 4 , and 5 that nitroglycerin reduced blood flow in normal animals compared to saline controls during exercise in the renal, splanchnic, and cutaneous beds, respectively. This effect could be the result of a sympathetic reflex activation secondary to the fall in mean arterial blood pressure noted in Figure ID . In the rats with heart failure, as in the patient, it is likely that there is an elevated sympathetic reflex activity that acts as a protective mechanism to maintain blood pressure at a level that allows adequate perfusion of the critical circulatory beds (coronary and cerebral). This mechanism, which would be enhanced during exercise, would account for the dramatically reduced blood flow levels in the renal, splanchnic, and cutaneous beds observed in the rats with heart failure during saline infusion. It has been suggested that this reflex may actually be "overprotective" in heart failure, resulting in a harmful increase in impedance to left ventricular ejection (Zeus etal., 1979) . Nitroglycerin and other vasodilators probably attenuate the effect of this reflex, not only in heart failure, but also in the normal animal-resulting, in the group with heart failure-in a net increase in regional blood flow and a reduction in impedance to left ventricular ejection and-in the normals-in a reduction in blood pressure, thereby inducing hypotension and subsequent sympathetic over-reactivation. Thus, nitroglycerin appears to be a complex drug whose effects in both normals and patients with heart failure is tempered to varying degrees by the underlying level of sympathetic activity.
In summary, acute nitroglycerin therapy in rats with heart failure reduces vascular resistance in the renal, splanchnic, and cutaneous circulations resulting in a reduction in cardiac afterload and an increase in the regional blood flow in these circulations. However, nitroglycerin may not increase exercise tolerance, since blood flow to the skeletal muscle bed is not affected significantly.
